Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:211189rdf:typepubmed:Citationlld:pubmed
pubmed-article:211189lifeskim:mentionsumls-concept:C0019351lld:lifeskim
pubmed-article:211189lifeskim:mentionsumls-concept:C0206679lld:lifeskim
pubmed-article:211189lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:211189lifeskim:mentionsumls-concept:C0007603lld:lifeskim
pubmed-article:211189lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:211189lifeskim:mentionsumls-concept:C1536403lld:lifeskim
pubmed-article:211189lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:211189lifeskim:mentionsumls-concept:C0205332lld:lifeskim
pubmed-article:211189pubmed:issue2lld:pubmed
pubmed-article:211189pubmed:dateCreated1978-11-18lld:pubmed
pubmed-article:211189pubmed:abstractTextSurface antigens of BHK-21 cells infected with HSV-1 or HSV-2 were radioiodinated (125I) with lactoperoxidase, immune precipitated and analysed by polyacrylamide gel electrophoresis (PAGE). Experiments using antiserum to HSV-1 or HSV-2, absorbed with appropriate hemotypic or heterotypic antigens, revealed that both type-specific (homotypic) and cross-reactive antibody combined with surface glycoproteins to form a single large radioactive peak. This peak, which constituted the major glycoprotein region (region a) observed in electropherograms, represented a range in mol. wt. from 115000 to 130000. Sensitization of cells to complement lysis, neutralization of infectious virus and immune precipitation of surface glycoproteins (region a) were found to be generally correlated properties of all the antibody preparations analysed, including antibody prepared specifically against region a antigens. These findings suggest a major immunological role for the surface glycoproteins migrating in PAGE region a.lld:pubmed
pubmed-article:211189pubmed:languageenglld:pubmed
pubmed-article:211189pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:211189pubmed:citationSubsetIMlld:pubmed
pubmed-article:211189pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:211189pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:211189pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:211189pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:211189pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:211189pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:211189pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:211189pubmed:statusMEDLINElld:pubmed
pubmed-article:211189pubmed:monthAuglld:pubmed
pubmed-article:211189pubmed:issn0022-1317lld:pubmed
pubmed-article:211189pubmed:authorpubmed-author:SmithJ WJWlld:pubmed
pubmed-article:211189pubmed:authorpubmed-author:WilsonL ALAlld:pubmed
pubmed-article:211189pubmed:authorpubmed-author:GloriosoJ CJClld:pubmed
pubmed-article:211189pubmed:authorpubmed-author:FengerT WTWlld:pubmed
pubmed-article:211189pubmed:issnTypePrintlld:pubmed
pubmed-article:211189pubmed:volume40lld:pubmed
pubmed-article:211189pubmed:ownerNLMlld:pubmed
pubmed-article:211189pubmed:authorsCompleteYlld:pubmed
pubmed-article:211189pubmed:pagination443-54lld:pubmed
pubmed-article:211189pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:211189pubmed:meshHeadingpubmed-meshheading:211189-A...lld:pubmed
pubmed-article:211189pubmed:meshHeadingpubmed-meshheading:211189-I...lld:pubmed
pubmed-article:211189pubmed:meshHeadingpubmed-meshheading:211189-C...lld:pubmed
pubmed-article:211189pubmed:meshHeadingpubmed-meshheading:211189-R...lld:pubmed
pubmed-article:211189pubmed:meshHeadingpubmed-meshheading:211189-G...lld:pubmed
pubmed-article:211189pubmed:meshHeadingpubmed-meshheading:211189-S...lld:pubmed
pubmed-article:211189pubmed:meshHeadingpubmed-meshheading:211189-A...lld:pubmed
pubmed-article:211189pubmed:meshHeadingpubmed-meshheading:211189-V...lld:pubmed
pubmed-article:211189pubmed:meshHeadingpubmed-meshheading:211189-C...lld:pubmed
pubmed-article:211189pubmed:meshHeadingpubmed-meshheading:211189-A...lld:pubmed
pubmed-article:211189pubmed:meshHeadingpubmed-meshheading:211189-A...lld:pubmed
pubmed-article:211189pubmed:meshHeadingpubmed-meshheading:211189-A...lld:pubmed
pubmed-article:211189pubmed:meshHeadingpubmed-meshheading:211189-A...lld:pubmed
pubmed-article:211189pubmed:year1978lld:pubmed
pubmed-article:211189pubmed:articleTitleComplement-mediated cytolysis of HSV-1 and HSV-2 infected cells: plasma membrane antigens reactive with type-specific and cross-reactive antibody.lld:pubmed
pubmed-article:211189pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:211189pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:211189lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:211189lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:211189lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:211189lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:211189lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:211189lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:211189lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:211189lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:211189lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:211189lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:211189lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:211189lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:211189lld:pubmed